Cary Street Partners Investment Advisory’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45	Closed	-$1.65K	–	1736
2022 Q4	$1.65K	Buy	+45	New	+$1.78K	﹤0.01%	1529

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Cary Street Partners Investment Advisory's SYNH Position: Q1 2023 in Review

Cary Street Partners Investment Advisory sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 45 shares — an estimated $1.65K sold.

Cary Street Partners Investment Advisory first reported a position in SYNH in Q4 2022 and held it in 1 quarter. The position peaked at $1.65K in Q4 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

Cary Street Partners Investment Advisory reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 45 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.65K.
Cary Street Partners Investment Advisory first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
Cary Street Partners Investment Advisory's Syneos Health, Inc. Class A Common Stock position peaked at $1.65K in Q4 2022.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q1 2023, filed 12 May 2023.